经尿道双极汽化治疗前列腺增生的远期疗效

PROSTECDTIVE EFFICACY OF TRANSURETHRAL BIPOLAR PLASMAKINETIC VAPORIZATION TREATED BENIGN PROSTATIC HYPERPLASIA

目的评价经尿道前列腺双极汽化术(TUBVP)治疗良性前列腺增生(BPH)的远期疗效。方法选取BPH患者100例,随机分为:观察组采用TUBVP术,对照组采用开放手术。比较其国际前列腺症状评分(IPSS)、生活质量评分(QOL)、最大尿流率(Qmax)、残余尿量(PRV)及远期并发症的发生率等情况。结果TUBVP组与开放手术组的各项指标,术前分别为IPSS(26.1±7.6)和(26.7±5.9)分,QOL(4.2±3.4)和(4.5±0.8)分,Qmax(7.6±5.7)和(7.4±4.5)ml/s,PRV((75±43)和(78±48)ml,二组比较差异无统计学意义,P>0.05。术后分别为IPSS(6.6±4.6)和(5.5±8.8)分,QOL(1.3±0.5)和(1.8±0.6)分,Qmax(20.0±10.2)和(19.5±9.3)ml/s。PRV(42±24)和(35±28)ml。二组比较差异无统计学意义,P>0.05。结论TUBVP与开放手术的远期疗效基本相同。

Objective To evaluate the prostecdtive efficacy of transurethral bipolar plasmakinetic vaporization treated benign prostatic hyperplasia. Methods 100 patients with BPH were randomized into TUBVP group and open surgery group, and we compared IPSS, QOL, Qmax, PRV and incidence rate of long- term complication in the two groups. Results The means of IPSS,QOL,Qmax,and PRV were all comparable respectively, preoperations of IPSS in the two groups were（26.1 ± 7.6）vs （26.7 ± 5.9 ）, QOL were（4.2 ± 3.4 ） vs（4.5 ± 0.8 ）, Qmax were（7.6 ± 5.7 ） ml/s vs（ 7.4 ± 4.5 ） ml/s, PRV were （75 ± 43 ） ml/s vs （78 ± 48） ml, （P 〉 0.05） ; Postoperations of IPSS in the two groups were（6.6 ± 4.6） vs （5.5 ± 8.8）, QOL were（ 1.3 ± 0.5）vs（ 1.8 ± 0.6）, Qmax were（20.0 ± 10.2 ） ml/s vs（ 19.5 ± 9.3 ） ml/s, PRV were（42 ± 24） ml vs（35 ± 28） ml, （ P 〉 0.05）. Conclusion The long- term outcom confirms that TUBVP is as effective as open surgey in treatment of BPH.